These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23152933)

  • 1. Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy.
    Loy RE; Lueck JD; Mostajo-Radji MA; Carrell EM; Dirksen RT
    PLoS One; 2012; 7(11):e49757. PubMed ID: 23152933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
    Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
    J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
    Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
    Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive Accumulation of Ca
    Canato M; Capitanio P; Cancellara L; Leanza L; Raffaello A; Reane DV; Marcucci L; Michelucci A; Protasi F; Reggiani C
    Front Physiol; 2019; 10():1142. PubMed ID: 31607937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin.
    Knoblauch M; Dagnino-Acosta A; Hamilton SL
    Skelet Muscle; 2013 Sep; 3(1):22. PubMed ID: 24004537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
    Feng W; Barrientos GC; Cherednichenko G; Yang T; Padilla IT; Truong K; Allen PD; Lopez JR; Pessah IN
    Mol Pharmacol; 2011 Mar; 79(3):420-31. PubMed ID: 21156754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I4895T mutation in the type 1 ryanodine receptor induces fiber-type specific alterations in skeletal muscle that mimic premature aging.
    Boncompagni S; Loy RE; Dirksen RT; Franzini-Armstrong C
    Aging Cell; 2010 Dec; 9(6):958-70. PubMed ID: 20961389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods.
    Zvaritch E; Kraeva N; Bombardier E; McCloy RA; Depreux F; Holmyard D; Kraev A; Seidman CE; Seidman JG; Tupling AR; MacLennan DH
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21813-8. PubMed ID: 19959667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific differences in ryanodine receptor 1 mRNA expression levels may contribute to phenotypic variability in malignant hyperthermia.
    Grievink H; Stowell KM
    Orphanet J Rare Dis; 2010 May; 5():10. PubMed ID: 20482855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
    Barrientos GC; Feng W; Truong K; Matthaei KI; Yang T; Allen PD; Lopez JR; Pessah IN
    J Biol Chem; 2012 Jan; 287(4):2863-76. PubMed ID: 22139840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle spindles exhibit core lesions and extensive degeneration of intrafusal fibers in the Ryr1(I4895T/wt) mouse model of core myopathy.
    Zvaritch E; MacLennan DH
    Biochem Biophys Res Commun; 2015 Apr; 460(1):34-9. PubMed ID: 25619131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
    Avila G; Dirksen RT
    J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
    Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium dependent rescue of a myopathy with core-like structures in mouse.
    Hanson MG; Wilde JJ; Moreno RL; Minic AD; Niswander L
    Elife; 2015 Jan; 4():. PubMed ID: 25564733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.